Enterprise Financial Services Corp (EFSC)’s Clovis Oncology, Inc. CLVS Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-64	Closed	-$1K	–	1063
2016 Q1	$1K	Sell	64 -40	-38%	-$847	﹤0.01%	1012
2015 Q4	$4K	Sell	104 -55	-35%	-$3.55K	﹤0.01%	793
2015 Q3	$15K	Hold	159	–	–	0.01%	459
2015 Q2	$14K	Buy	159 +34	+27%	+$2.91K	0.01%	491
2015 Q1	$9K	Hold	125	–	–	0.01%	654
2014 Q4	$7K	Buy	125 +40	+47%	+$2.1K	﹤0.01%	715
2014 Q3	$4K	Buy	85 +9	+12%	+$376	﹤0.01%	857
2014 Q2	$3K	Hold	76	–	–	﹤0.01%	979
2014 Q1	$5K	Buy	76 +12	+19%	+$881	﹤0.01%	837
2013 Q4	$4K	Hold	64	–	–	﹤0.01%	854
2013 Q3	$4K	Hold	64	–	–	﹤0.01%	831
2013 Q2	$4K	Buy	+64	New	+$2.88K	﹤0.01%	706

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s CLVS Position: Q2 2016 in Review

Enterprise Financial Services Corp (EFSC) sold out of Clovis Oncology, Inc. (CLVS) in Q2 2016, closing a stake of 64 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in CLVS in Q2 2013 and held it in 12 quarters. The position peaked at $15K in Q3 2015. 122 funds tracked by Wall St. Rank hold CLVS as of Q2 2016.

Enterprise Financial Services Corp (EFSC) reported no remaining Clovis Oncology, Inc. position as of Q2 2016 after selling out during the quarter.
Enterprise Financial Services Corp (EFSC) sold 64 Clovis Oncology, Inc. shares in Q2 2016, an estimated $1K.
Enterprise Financial Services Corp (EFSC) first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 12 quarters.
Enterprise Financial Services Corp (EFSC)'s Clovis Oncology, Inc. position peaked at $15K in Q3 2015.
122 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2016.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q2 2016, filed 29 Jul 2016.